4703-53-1

Basic information

• Product Name: N-benzyloxycarbonylleucinehydrazid
• CAS NO: 4703-53-1
• Molecular Weight: 279.339
• Mol File: 4703-53-1.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: N-benzyloxycarbonylleucinehydrazid(CAS DataBase Reference)
• NIST Chemistry Reference: N-benzyloxycarbonylleucinehydrazid(4703-53-1)
• EPA Substance Registry System: N-benzyloxycarbonylleucinehydrazid(4703-53-1)

Safety Data

• Hazardous Substances Data: 4703-53-1(Hazardous Substances Data)

Upstream product

• 51021-87-5 N-benzyloxycarbonyl-L-leucine methyl ester 
• 501-53-1 benzyl chloroformate 
• 73397-22-5 Cbz-D-Leu-OMe 
• 23032-21-5 D-leucine methyl ester 
• 67-66-3 chloroform 
• 7803-57-8 hydrazine hydrate 
• 61-90-5 L-leucine 
• 7517-19-3 methyl (L)-leucinate hydrochloride 
• 2666-93-5 (S)-Leu-OMe 
• 58889-73-9 (S)-N-benzyloxycarbonyl-leucine ethyl ester 

Downstream Products

• 56877-55-5 N^α-(N-benzyloxycarbonyl-D-leucyl)-L-tryptophan-methyl ester 
• 13588-95-9 L-leucyl-L-valine 
• 103238-78-4 Benzyloxycarbonyl-L-leucyl-L-valin-benzylester 
• 190660-78-7 (1S)-1-benzyloxycarbonylamino-3-methyl-1-(1,3,4-oxadiazol-2-on-5-yl)butane 
• 2873-36-1 cyclo(L-Pro-L-Leu) 
• 87024-12-2 (S)-1-(2'-benzyloxycarbonylamino-4'-methylpentanoyl)-3,5-dimethylpyrazole 
• 88491-28-5 (S)-N-benzyloxycarbonyl-N'-ethoxycarbonyl-3-methylbutane-1,1-diamine 
• 88491-35-4 (R)-N-benzyloxycarbonyl-N'-p-methoxybenzyloxycarbonyl-3-methylbutane-1,1-diamine 
• 1352815-92-9 C₂₆H₂₅N₃O₅ 
• 1356072-77-9 benzyl (1S)-1-isobutyl-2-{(2E/Z)-2-[(5-nitro-2-furyl)-methylene]hydrazine}-2-oxoethylcarbamate 
• 1360470-89-8 C₂₂H₃₁N₃O₅S 
• 1246168-80-8 C₁₉H₂₈N₄O₅S 
• 20806-85-3 N-[N-(N-benzyloxycarbonyl-L-leucyl)-glycyl]-glycine ethyl ester 
• 14297-22-4 N-[N-(N-benzyloxycarbonyl-L-leucyl)-glycyl]-glycine 

Relevant articles and documents

AMINOCARBAMOYL COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS

The present invention relates to compounds of formula (II) wherein R1-R5, X and L are as described herein, and pharmaceutically acceptable salts thereof, compositions including the compounds and methods of using the compounds, particularly in the treatment and prophylaxis of coronavirus infection.

Synthesis and Antitubercular Activity of Novel Amino Acid Derivatives

In this work, 17 new N-acylhydrazone derivatives of amino acids have been evaluated for their in vitro antibacterial activity against Mycobacterium tuberculosis H37Rv. The compounds 8b, 8e, 8f, 9a-d, and 10c exhibited an important minimum inhibitory concentration activity between 12.5 and 50μg/mL, which can be compared with that of the tuberculostatic drug d-cycloserine (20μg/mL). In this work 17 new N-acylhydrazone derivatives of amino acids have been evaluated for their in vitro antibacterial activity against Mycobacterium tuberculosis H37Rv. Eight compounds were non-cytotoxic and exhibited an important MIC activity between 12.5 and 50μg/mL, which can be compared with that of the tuberculostatic drug d-cycloserine (20μg/mL).

A family of strong low-molecular-weight organogelators based on aminoacid derivatives

A new family of potent aminoacid-type organogelators obtained via an easy and unexpensive way is described. We demonstrated that structural variations onto the side chains of the aminoacid derivatives allowed modulations of the gelation properties. The or